Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.58 USD | +2.87% | +5.29% | +110.59% |
25/04 | ARCA biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
19/04 | North American Morning Briefing : Stock Futures -2- | DJ |
Chart calendar ARCA biopharma, Inc.
Upcoming events on ARCA biopharma, Inc.
Past events on ARCA biopharma, Inc.
26/04/2024 01:45 am | Q1 2024 Earnings Release |
03/04/2024 06:00 pm | ARCA biopharma, Inc. and Oruka Therapeutics Merger Call |
02/02/2024 03:05 am | Q4 2023 Earnings Release |
30/01/2024 09:30 pm | Annual General Meeting |
22/07/2023 01:55 am | Q2 2023 Earnings Release |
25/02/2023 02:50 am | Q4 2022 Earnings Release |
15/12/2022 09:30 pm | Annual General Meeting |
29/10/2022 01:45 am | Q3 2022 Earnings Release |
03/08/2022 01:45 am | Interim 2022 Earnings Release |
03/05/2022 01:45 am | Q1 2022 Earnings Release |
15/03/2022 01:45 am | FY 2021 Earnings Release |
18/11/2021 02:45 am | FY Virtual Investor Summit |
03/11/2021 01:45 am | Q3 2021 Earnings Release |
05/08/2021 01:45 am | Interim 2021 Earnings Release |
13/07/2021 11:30 pm | Issuer Direct Access to Giving Virtual Investor Conference |
08/07/2021 | Annual General Meeting |
12/05/2021 01:45 am | Q1 2021 Earnings Release |
19/03/2021 02:00 am | FY 2020 Earnings Release |
10/12/2020 09:30 pm | Annual General Meeting |
02/11/2020 07:00 pm | Q3 2020 Earnings Release |
Annual results
Fiscal Period | December | 2019 |
---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - |
EBITDA Million USD | Released Forecast Spread | -5,65 -5,70 0.96% |
EBIT Million USD | Released Forecast Spread | -5,81 -6,10 4.69% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,65 -6,00 5.85% |
Net income Million USD | Released Forecast Spread | -5,48 -5,80 5.48% |
EPS USD | Released Forecast Spread | -4,15 -4,42 6.11% |
Announcement Date | 18/02/20 |
Past sector events for ARCA biopharma, Inc.
- Stock Market
- Equities
- ABIO Stock
- Calendar ARCA biopharma, Inc.